Myeloid HIF-1α Sustains Hypoxic Fibrotic Fronts and Drives Pulmonary Fibrosis
This study identifies myeloid HIF-1α as a critical driver of pulmonary fibrosis that sustains hypoxic fibrotic fronts by promoting macrophage persistence and fibroblast activation, demonstrating that targeting this pathway via lung-directed therapies effectively attenuates disease progression.